Tenofovir alafenamide

Chemical formula: C₂₁H₂₉N₆O₅P  Molecular mass: 476.474 g/mol  PubChem compound: 9574768

Therapeutic indications

Tenofovir alafenamide is indicated for:

Chronic hepatitis B

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Tenofovir alafenamide is indicated for the treatment of chronic hepatitis B (CHB) in adults and paediatric patients 6 years of age and older weighing at least 25 kg.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Tenofovir alafenamide is contraindicated in the following cases:

Lactation

Lactation

Medicinal products containing tenofovir alafenamide, tenofovir disoproxil fumarate, adefovir dipivoxil

at least one of
Tenofovir alafenamide
Tenofovir disoproxil
Adefovir dipivoxil

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: VEMLIDY Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈